NSE filing, NSE: CLSL. Summary written from the filing by ALFA Finder's alert engine.
Crop Life Science Ltd: key numbers
- Share price
- ₹82.00
- Market cap
- ₹140.6 Cr
- Revenue (annual)
- ₹207.2 Cr
- Net profit (annual)
- ₹6.64 Cr
- P/E (TTM)
- 21.2×Sector 34.1×
- Promoter holding
- 67.21%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crop Life Science Ltd
All →Crop Life Science Management Change
Crop Life Science Limited accepted the resignation of two Independent Directors and approved the reconstitution of its Board committees.
Crop Life Science Management Change
Crop Life Science Ltd. appointed Mr. Alpeshbhai Gordhanbhai Vaghasiya as an Independent Director. This appointment was approved by shareholders at the 20th Annual General Meeting.
Crop Life Science Annual General Meeting
Crop Life Science Limited held its 20th Annual General Meeting on September 23, 2026. The proceedings covered ordinary and special business resolutions for the shareholders.
Crop Life Science Annual General Meeting
Crop Life Science Limited dispatched letters to non-email registered shareholders providing the web-link for the FY 2025-26 Annual Report. The 20th AGM is scheduled for September 23, 2026.
Crop Life Science Annual General Meeting
Crop Life Science Limited scheduled its 20th Annual General Meeting for September 23, 2026. The board also deferred a proposal for incorporating a wholly-owned overseas subsidiary.
Crop Life Science Board Meeting Date
Crop Life Science Limited has scheduled a board meeting for August 24, 2026. The board will discuss incorporating a wholly-owned subsidiary in Dubai and AGM arrangements.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.